Works matching IS 14752840 AND DT 2004 AND VI 3

Results: 10

The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481].
Published in:
Cardiovascular Diabetology, 2004, v. 3, p. 9, doi. 10.1186/1475-2840-3-9
Publication type:
Article
Ciprofibrate therapy in patients with hypertriglyceridemia and low high density lipoprotein (HDL)-cholesterol: greater reduction of non-HDL cholesterol in subjects with excess body weight (The CIPROAMLAT study).
Published in:
Cardiovascular Diabetology, 2004, v. 3, p. 8, doi. 10.1186/1475-2840-3-8
By:
- Aguilar-Salinas, Carlos A.;
- Assis-Luores-Vale, Andréia;
- Stockins, Benjamín;
- Rengifo, Hector Mario;
- Filho, José Dondici;
- Neto, Abrahão Afiune;
- Rabelo, Lísia Marcílio;
- Torres, Kerginaldo Paulo;
- De Oliveira, José Egídio Paulo;
- Machado, Carlos Alberto;
- Reyes, Eliana;
- Saavedra, Victor;
- Florenzano, Fernando;
- Hernández, Ma Victoria;
- Jiménez, Sergio Hernandez;
- Ramírez, Erika;
- Vazquez, Cuauhtémoc;
- Salinas, Saul;
- Hernández, Ismael;
- Medel, Octavio
Publication type:
Article
Plasma matrix metalloproteinases, low density lipoprotein oxidisability and soluble adhesion molecules after a glucose load in Type 2 diabetes.
Published in:
Cardiovascular Diabetology, 2004, v. 3, p. 7, doi. 10.1186/1475-2840-3-7
By:
- Sampson, Mike;
- Davies, Isabel;
- Gavrilovic, Jelena;
- Sussams, Brendan;
- Brown, Jackie;
- Astley, Sian;
- Hughes, David A.
Publication type:
Article
Arterial heparan sulfate is negatively associated with hyperglycemia and atherosclerosis in diabetic monkeys.
Published in:
Cardiovascular Diabetology, 2004, v. 3, p. 6, doi. 10.1186/1475-2840-3-6
By:
- Edwards, Iris J.;
- Wagner, Janice D.;
- Vogl-Willis, Catherine A.;
- Litwak, Kenneth N.;
- Cefalu, William T.
Publication type:
Article
Metabolic and cardiovascular improvements after biliopancreatic diversion in a severely obese patient.
Published in:
Cardiovascular Diabetology, 2004, v. 3, p. 5, doi. 10.1186/1475-2840-3-5
By:
- Woods, Philippe;
- Paquette, Carmen;
- Martin, Julie;
- Dumesnil, Jean-Gaston;
- Marceau, Picard;
- Marceau, Simon;
- Biron, Simon;
- Hould, Frédéric;
- Lescelleur, Odette;
- Lebel, Stéphane;
- Poirier, Paul
Publication type:
Article
Neurohumoral stimulation in type-2-diabetes as an emerging disease concept.
Published in:
Cardiovascular Diabetology, 2004, v. 3, p. 4, doi. 10.1186/1475-2840-3-4
By:
- Pliquett, R. U.;
- Fasshauer, M.;
- Blüher, M.;
- Paschke, R.
Publication type:
Article
Cardiovascular adaptations to exercise training in postmenopausal women with type 2 diabetes mellitus.
Published in:
Cardiovascular Diabetology, 2004, v. 3, p. 3, doi. 10.1186/1475-2840-3-3
By:
- McGavock, Jonathan;
- Mandic, Sandra;
- Lewanczuk, Richard;
- Koller, Matthew;
- Muhll, Isabelle Vonder;
- Quinney, Arthur;
- Taylor, Dylan;
- Welsh, Robert;
- Haykowsky, Mark
Publication type:
Article
An interaction between the interleukin-6 -174G>C gene variant and urinary protein excretion influences plasma oxidative stress in subjects with type 2 diabetes.
Published in:
Cardiovascular Diabetology, 2004, v. 3, p. 2, doi. 10.1186/1475-2840-3-2
By:
- Stephens, Jeffrey W.;
- Hurel, Steven J.;
- Acharya, Jayshree;
- Humphries, Steve E.
Publication type:
Article
Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: fibrates, statins or both?
Published in:
Cardiovascular Diabetology, 2004, v. 3, p. 1, doi. 10.1186/1475-2840-3-10
By:
- Tenenbaum, Alexander;
- Fisman, Enrique Z.
Publication type:
Article
Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation.
Published in:
Cardiovascular Diabetology, 2004, v. 3, p. 1, doi. 10.1186/1475-2840-3-1
By:
- Hayden, Melvin R.;
- Tyagi, Suresh C.
Publication type:
Article